Journal Article

DKFZ-2025-02269

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png AI-powered spatial cell phenomics enhances risk stratification in non-small cell lung cancer.

Schallenberg, S. ; Dernbach, G. ; Ruane, S. ; Jurmeister, P. ; Böhm, C. ; Standvoss, K. ; Ghosh, S. ; Frentsch, M. ; Dragomir, M.-P.DKFZ* ; Keyl, P. G. ; Friedrich, C. ; Na, I.-K.DKFZ* ; Merkelbach-Bruse, S. ; Quaas, A. ; Frost, N. ; Boschung, K. ; Randerath, W. ; Schlachtenberger, G. ; Heldwein, M. ; Keilholz, U. ; Hekmat, K. ; Rückert, J.-C. ; Büttner, R. ; Vasaturo, A. ; Horst, D. ; Ruff, L. ; Alber, M. ; Müller, K.-R. ; Klauschen, F.DKFZ*

2025
Springer Nature [London]

This record in other databases:  

Please use a persistent id in citations: doi:10.1038/s41467-025-65783-z

Abstract: Risk stratification remains a critical challenge in non-small cell lung cancer patients for optimal therapy selection. In this study, we develop an artificial intelligence-powered spatial cellomics approach that combines histology, multiplex immunofluorescence imaging and multimodal machine learning to characterize the complex cellular relationships of 43 cell phenotypes in the tumor microenvironment in a real-world retrospective cohort of 1168 non-small cell lung cancer patients from two large German cancer centers. The model identifies cell niches associated with survival and achieves a 14% and 47% improvement in risk stratification in the two main non-small cell lung cancer subtypes, lung adenocarcinoma and squamous cell carcinoma, respectively, combining niche patterns with conventional cancer staging. Our results show that complex immune cell niche patterns identify potentially undertreated high-risk patients qualifying for adjuvant therapy. Our approach highlights the potential of artificial intelligence powered multiplex imaging analyses to better understand the contribution of the tumor microenvironment to cancer progression and to improve risk stratification and treatment selection in non-small cell lung cancer.

Keyword(s): Humans (MeSH) ; Carcinoma, Non-Small-Cell Lung: pathology (MeSH) ; Carcinoma, Non-Small-Cell Lung: mortality (MeSH) ; Carcinoma, Non-Small-Cell Lung: diagnostic imaging (MeSH) ; Lung Neoplasms: pathology (MeSH) ; Lung Neoplasms: mortality (MeSH) ; Tumor Microenvironment (MeSH) ; Female (MeSH) ; Male (MeSH) ; Artificial Intelligence (MeSH) ; Retrospective Studies (MeSH) ; Phenomics: methods (MeSH) ; Middle Aged (MeSH) ; Aged (MeSH) ; Risk Assessment: methods (MeSH) ; Machine Learning (MeSH) ; Carcinoma, Squamous Cell: pathology (MeSH)

---

Contributing Institute(s):

1. DKTK Koordinierungsstelle Berlin (BE01)
2. DKTK Koordinierungsstelle München (MU01)

Research Program(s):

1. 899 - ohne Topic (POF4-899) (POF4-899)

Appears in the scientific report 2025

---

Database coverage:
; ; ; Article Processing Charges ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Agriculture, Biology and Environmental Sciences ; Current Contents - Life Sciences ; Current Contents - Physical, Chemical and Earth Sciences ; DOAJ Seal ; Essential Science Indicators ; Fees ; IF >= 15 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection ; Zoological Record

---